Log in or Sign up for Free to view tailored content for your specialty!
Hypertension News
Dapagliflozin fails to prevent organ damage, death in adults hospitalized with COVID-19
Top-line data from the phase 3 DARE-19 trial show that the SGLT2 inhibitor dapagliflozin failed to prevent organ dysfunction and all-cause mortality among hospitalized patients with COVID-19 at risk for developing serious complications.
‘Hypertension’ and ‘high-normal’ labels may cause more harm than good in low-risk patients
Labeling low-risk individuals based on a high BP reading led to increased worry and disease perceptions and no changes in willingness to make lifestyle changes, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
Beta-blockers independently associated with CVD, death in veterans with HIV
Among veterans with HIV and new-onset hypertension, beta-blockers were independently associated with increased risk for incident CVD or death compared with ACE inhibitors or angiotensin receptor blockers, researchers reported.
Racial CVD disparities minimally improved in rural areas over past 2 decades
From 1999 to 2018, Black adults in rural communities continuously experienced greater risk for death from diabetes, hypertension, heart disease and stroke compared with white adults, researchers reported.
KDIGO updates 2012 guideline on managing blood pressure in CKD, largely informed by SPRINT
Kidney Disease: Improving Global Outcomes has revised its guideline on managing blood pressure in patients with chronic kidney disease. The guideline was originally published in 2012.
Different nocturnal hypertension entities show varying impact on outcomes in CKD
Nocturnal systolic hypertension conferred a higher likelihood of adverse kidney and cardiovascular outcomes in patients with chronic kidney disease, according to a study that compared different nocturnal hypertension entities.
Family history of ESKD shows no impact on long-term outcomes for African American donors
Having a first-degree relative with a history of end-stage kidney disease did not appear to increase the risk for long-term kidney function decline or hypertension in African American kidney donors, according to study results.
Phosphate-lowering drug may increase blood pressure in patients with CKD
Phosphate binder lanthanum carbonate increased systolic blood pressure in patients with chronic kidney disease, leading researchers to suggest the drug “may reduce gastrointestinal absorption of antihypertensive medications.”
eGFR variability linked to greater mortality risk but not cardiovascular events
For patients with hypertension, variation in eGFR measurements over time appeared to increase risk for all-cause mortality but did not demonstrate an association with cardiovascular events.
BP control may impact decline in cognitive function
BP control may be critical for the preservation of cognitive function, according to a study published in Hypertension.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read